Idexx Laboratories (IDXX) Asset Writedowns and Impairment (2009 - 2026)

Idexx Laboratories' Asset Writedowns and Impairment history runs 16 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (changed N/A YoY), while the FY2024 annual figure was $250000.0, down 83.15% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $5.0 million, up from $250000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $5.0 million in Q1 2026, with the low at $250000.0 in Q1 2024.
• The 3-year median for Asset Writedowns and Impairment is $1.5 million (2023), against an average of $2.2 million.